Clinical Trial Update: Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating induction docetaxel/cisplatin/5-fluorouracil (TPF) as a selector between chemoradiation therapy and partial laryngectom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngeal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• Docetaxel (Taxotere) (docetaxel)

Snippet

Sponsor: Rabin Medical Center | Conditions: Larynx Cancer | Phase 2 | Status: UNKNOWN